MBL (Medical & Biological Laboratories Co., Ltd.)

MBL began its history as the first Japanese company specializing in the production and supply of antibodies and celebrated its 50th anniversary in August 2019. In the 1970s, for the first time in Japan, we began to develop autoimmune disease reagents and succeeded in launching a series of autoantibody reagents. Currently, these reagent products are our main-stream business. In the 1980s, we expanded business into the field of laboratory research reagents and launched many original products such as antiserum and monoclonal antibodies, IL-18 products, and MHC tetramers. Starting in the 2000s, we began to promote sales of molecular diagnostic reagents,...

In vitro diagnostics,companion diagnostics,cancer,autoimmune diseases,covid-19,cancer immunity,organoid,nudt15,mhc tetramers,il-18,and ifa

Mbl (medical & biological laboratories co., ltd.) operates in the Medical equipment manufacturing industry.

Mbl (medical & biological laboratories co., ltd.)'s revenue is 11m - 100m

Mbl (medical & biological laboratories co., ltd.) has 11 - 50 employees.